Report Detail
Global Viral Vectors and Plasmid DNA Manufacturing Market Growth (Status and Outlook) 2019-2024
- RnM3002212 |
- 22 February, 2019 |
- Global |
- 137 Pages |
- LPI(LP Information) |
- Other
The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.
Based on classification, the proportion of Viral Vectors Manufacturing in 2016 is about 79.74%, with revenue about 200 M USD. Based on application, Cancers segment accounted for larger market share in terms of sales in 2016, vascular segmented accounted for more than 61% of the market share in 2016.
North America is the largest consumption place, with a consumption market share nearly 51% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 34% in 2016.
Market competition is intense among top 5. BioReliance, Cobra Biologics, Oxford BioMedica, UniQure, FinVector are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Viral Vectors and Plasmid DNA Manufacturing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Viral Vectors and Plasmid DNA Manufacturing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares and growth opportunities of Viral Vectors and Plasmid DNA Manufacturing market by product type, application, key companies and key regions.
This study considers the Viral Vectors and Plasmid DNA Manufacturing value generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Plasmid DNA
Viral Vectors
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Cancers
Inherited Disorders
Viral Infections
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
BioReliance
Cobra Biologics
Oxford BioMedica
UniQure
FinVector
MolMed
MassBiologics
Richter-Helm
FUJIFILM Diosynth Biotechnologies
Lonza
Aldevron
Eurogentec
Cell and Gene Therapy Catapult
Biovian
Brammer Bio
VGXI
PlasmidFactory
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Viral Vectors and Plasmid DNA Manufacturing market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Viral Vectors and Plasmid DNA Manufacturing market by identifying its various subsegments.
Focuses on the key global Viral Vectors and Plasmid DNA Manufacturing players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Viral Vectors and Plasmid DNA Manufacturing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Viral Vectors and Plasmid DNA Manufacturing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Viral Vectors and Plasmid DNA Manufacturing Market Report (Status and Outlook)
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size 2014-2024
- 2.1.2 Viral Vectors and Plasmid DNA Manufacturing Market Size CAGR by Region
- 2.2 Viral Vectors and Plasmid DNA Manufacturing Segment by Type
- 2.2.1 Plasmid DNA
- 2.2.2 Viral Vectors
- 2.3 Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 2.3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2014-2019)
- 2.3.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Type (2014-2019)
- 2.4 Viral Vectors and Plasmid DNA Manufacturing Segment by Application
- 2.4.1 Cancers
- 2.4.2 Inherited Disorders
- 2.4.3 Viral Infections
- 2.4.4 Others
- 2.5 Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
- 2.5.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Application (2014-2019)
- 2.5.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Growth Rate by Application (2014-2019)
3 Global Viral Vectors and Plasmid DNA Manufacturing by Players
- 3.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Players
- 3.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size by Players (2017-2019)
- 3.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Players (2017-2019)
- 3.2 Global Viral Vectors and Plasmid DNA Manufacturing Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Viral Vectors and Plasmid DNA Manufacturing by Regions
- 4.1 Viral Vectors and Plasmid DNA Manufacturing Market Size by Regions
- 4.2 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size Growth
- 4.3 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size Growth
- 4.4 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Growth
- 4.5 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size Growth
5 Americas
- 5.1 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Countries
- 5.2 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 5.3 Americas Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Countries
- 6.2 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 6.3 APAC Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Viral Vectors and Plasmid DNA Manufacturing by Countries
- 7.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 7.3 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing by Countries
- 8.2 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Type
- 8.3 Middle East & Africa Viral Vectors and Plasmid DNA Manufacturing Market Size by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast
- 10.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast (2019-2024)
- 10.2 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Regions
- 10.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Regions (2019-2024)
- 10.2.2 Americas Market Forecast
- 10.2.3 APAC Market Forecast
- 10.2.4 Europe Market Forecast
- 10.2.5 Middle East & Africa Market Forecast
- 10.3 Americas Forecast by Countries
- 10.3.1 United States Market Forecast
- 10.3.2 Canada Market Forecast
- 10.3.3 Mexico Market Forecast
- 10.3.4 Brazil Market Forecast
- 10.4 APAC Forecast by Countries
- 10.4.1 China Market Forecast
- 10.4.2 Japan Market Forecast
- 10.4.3 Korea Market Forecast
- 10.4.4 Southeast Asia Market Forecast
- 10.4.5 India Market Forecast
- 10.4.6 Australia Market Forecast
- 10.5 Europe Forecast by Countries
- 10.5.1 Germany Market Forecast
- 10.5.2 France Market Forecast
- 10.5.3 UK Market Forecast
- 10.5.4 Italy Market Forecast
- 10.5.5 Russia Market Forecast
- 10.5.6 Spain Market Forecast
- 10.6 Middle East & Africa Forecast by Countries
- 10.6.1 Egypt Market Forecast
- 10.6.2 South Africa Market Forecast
- 10.6.3 Israel Market Forecast
- 10.6.4 Turkey Market Forecast
- 10.6.5 GCC Countries Market Forecast
- 10.7 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Type
- 10.8 Global Viral Vectors and Plasmid DNA Manufacturing Forecast by Application
11 Key Players Analysis
- 11.1 BioReliance
- 11.1.1 Company Details
- 11.1.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
- 11.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.1.4 Main Business Overview
- 11.1.5 BioReliance News
- 11.2 Cobra Biologics
- 11.2.1 Company Details
- 11.2.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
- 11.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.2.4 Main Business Overview
- 11.2.5 Cobra Biologics News
- 11.3 Oxford BioMedica
- 11.3.1 Company Details
- 11.3.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
- 11.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.3.4 Main Business Overview
- 11.3.5 Oxford BioMedica News
- 11.4 UniQure
- 11.4.1 Company Details
- 11.4.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
- 11.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.4.4 Main Business Overview
- 11.4.5 UniQure News
- 11.5 FinVector
- 11.5.1 Company Details
- 11.5.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
- 11.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.5.4 Main Business Overview
- 11.5.5 FinVector News
- 11.6 MolMed
- 11.6.1 Company Details
- 11.6.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
- 11.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.6.4 Main Business Overview
- 11.6.5 MolMed News
- 11.7 MassBiologics
- 11.7.1 Company Details
- 11.7.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
- 11.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.7.4 Main Business Overview
- 11.7.5 MassBiologics News
- 11.8 Richter-Helm
- 11.8.1 Company Details
- 11.8.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
- 11.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.8.4 Main Business Overview
- 11.8.5 Richter-Helm News
- 11.9 FUJIFILM Diosynth Biotechnologies
- 11.9.1 Company Details
- 11.9.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
- 11.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.9.4 Main Business Overview
- 11.9.5 FUJIFILM Diosynth Biotechnologies News
- 11.10 Lonza
- 11.10.1 Company Details
- 11.10.2 Viral Vectors and Plasmid DNA Manufacturing Product Offered
- 11.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Revenue, Gross Margin and Market Share (2017-2019)
- 11.10.4 Main Business Overview
- 11.10.5 Lonza News
- 11.11 Aldevron
- 11.12 Eurogentec
- 11.13 Cell and Gene Therapy Catapult
- 11.14 Biovian
- 11.15 Brammer Bio
- 11.16 VGXI
- 11.17 PlasmidFactory
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Viral Vectors and Plasmid DNA Manufacturing . Industry analysis & Market Report on Viral Vectors and Plasmid DNA Manufacturing is a syndicated market report, published as Global Viral Vectors and Plasmid DNA Manufacturing Market Growth (Status and Outlook) 2019-2024. It is complete Research Study and Industry Analysis of Viral Vectors and Plasmid DNA Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
